Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBP-6000 (Sublocade) Blockade Study in Opioid Use Disorder
NCT02044094Phase 2Completed
- Sponsor
- Indivior
- Start
- Nov 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Indivior. Started Nov 2013; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02044094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044094.